GLP-1 medications after menopause work, but without the right strategy, they can cost you the muscle and bone you can least afford to lose.
If you’re a woman over 50 taking a GLP-1 medication like semaglutide or tirzepatide, there’s a good chance the prescribing conversation skipped the part that matters most to you. Menopause changes how your body stores fat and builds muscle. A different dose alone won’t account for that.
Here’s what recent research actually says about GLP-1 use during and after menopause, the real risks for midlife women losing weight on these medications, and what you can actually do about it.
What Menopause Does To Your Metabolism
Menopause rearranges how your body handles energy. As estrogen falls, your resting metabolic rate drops, fat migrates from your hips and thighs toward your abdomen, and insulin sensitivity gets worse.
A 2015 study on cardiovascular fat and menopause found that as estrogen drops through the menopausal transition, fat doesn’t just pile up around the waist. It builds up around the heart. Women in late perimenopause and postmenopause had nearly 10% more epicardial fat and over 20% more paracardial fat than women who were still premenopausal, regardless of their age or overall weight.
Estrogen also affects appetite hormones and your body’s own GLP-1 production. When it drops, all of those systems shift at once. Hot flashes and night sweats wreck sleep, which throws off leptin and ghrelin, the hormones that control hunger and fullness.
None of this is a willpower problem. The biology of midlife makes weight management harder than it was at 35.
Do GLP-1 Medications After Menopause Actually Work?
Short answer: yes. A secondary analysis of the SURMOUNT clinical trials found that tirzepatide reduced body weight and waist circumference, regardless of whether women were premenopausal, perimenopausal, or postmenopausal. Most participants in these trials were women in their 50s, so the findings likely apply to other GLP-1 medications as well.
Here’s where it gets interesting. A separate 2024 study in Menopause found that postmenopausal women on semaglutide who also took hormone replacement therapy (HRT) lost about 33 percent more total body weight than those on semaglutide alone over 12 months. At every checkpoint, the combination group was more likely to hit milestones like 5 or 10 percent total body weight loss.
So the drugs work. But the context of midlife, where muscle loss and hormonal shifts are already happening, means the medication alone isn’t the whole story. You need protective strategies alongside it. For a deeper look at what that means in practice, this piece on GLP-1s and midlife women is worth your time.
The Muscle Problem
Any kind of weight loss costs you some lean body mass. GLP-1 medications are no different.
A 2024 review in Diabetes, Obesity and Metabolism found that lean mass reductions can account for 15 to 40 percent of total weight lost on GLP-1 therapies, depending on the drug and the people studied.
UC Davis exercise physiologist Keith Baar has pointed out that this ratio isn’t dramatically different from plain caloric restriction, but GLP-1 drugs cause weight to come off faster, which makes it harder to hold onto muscle.
Then there’s bone density. A 2024 randomized trial in JAMA Network Open found that GLP-1 therapy alone (liraglutide) reduced bone mineral density at the hip and spine. Adding exercise to treatment helped maintain density at the hip, spine, and forearm. If you’re postmenopausal and already at higher risk of osteoporosis, this isn’t something to monitor later. It’s something to monitor from the start.
You Need Strength Training and Protein
Two things come up again and again in the research on protecting muscle and bone during GLP-1 use: resistance exercise and enough protein.
A 2025 cross-sectional study found that postmenopausal women who ate at least 1.0 to 1.2 grams of protein per kilogram of body weight daily and did resistance exercise at least twice a week had stronger handgrip strength and lower odds of weakness than those who did neither.
In practice, many midlife women do well with a daily protein target of 1.2 to 1.6 g/kg, spread across meals rather than crammed into one sitting. For a 70-kilogram woman (about 154 pounds), that’s roughly 84 to 112 grams a day. Leucine-rich foods, things like whey protein, eggs, fish, and poultry, are especially good at triggering muscle protein synthesis in older adults.
And resistance training doesn’t have to mean barbells. Bodyweight exercises, bands, moderate dumbbell work, all of it counts. Strength training at least three times per week, along with 150 minutes of aerobic exercise, is a strong addition to your routine if you’re on a GLP-1 medication. If you haven’t trained before, working with a physical therapist or trainer who understands menopause is a good place to start.
What To Bring Up With Your Doctor
GLP-1 treatment in midlife deserves to be a real conversation, not a handoff. Before starting or continuing one of these medications, there are a few things worth raising with your provider.
Ask about baseline testing. A DEXA scan or body composition assessment gives you a starting picture of muscle mass and bone density, and both should be tracked over time. Bring up whether hormone replacement therapy makes sense for your situation.
Be honest about your current protein intake and activity level, because most women underestimate how much protein they actually eat. And talk about the pace of weight loss. GLP-1 drugs like Ozempic carry potential side effects around muscle and bone loss that are worth understanding before you start. Slower, supervised dose increases may be the smarter path for women who are already losing lean mass from menopause.
The Bottom Line
GLP-1 medications can help manage weight and metabolic risk during and after menopause. But they don’t do the whole job on their own. The hormonal reality of midlife means that protecting your bones and muscles and eating enough protein matter just as much as what the scale says.
FAQ: GLP-1 Medications After Menopause
Q. Do GLP-1 medications work after menopause?
A: Yes. Clinical trial data, including a post-hoc analysis of the SURMOUNT program, show that tirzepatide reduced body weight and waist circumference in postmenopausal women at rates comparable to premenopausal women.
Q. Can GLP-1 medications cause muscle loss in women over 50?
A: They can. Research shows lean mass can account for 15 to 40 percent of total weight lost on GLP-1 therapies. Resistance training and adequate protein intake of 1.2 to 1.6 grams per kilogram of body weight daily are the primary protective strategies.
Q. Does HRT improve results with GLP-1 medications after menopause?
A: A 2024 study found postmenopausal women taking semaglutide combined with hormone replacement therapy lost approximately 33 percent more total body weight over 12 months than those on semaglutide alone.
Q. What should women over 50 ask their doctor before starting a GLP-1 medication?
A: Ask about baseline DEXA scanning, the pace of dose increases, your current protein intake and activity level, and whether HRT is appropriate for your situation.
Disclaimer: This information is intended for general knowledge and informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before making changes to your medication, diet, or exercise routine. Individual results and risks vary.
Did you enjoy this contributed article? This post contains affiliate links. Sign-up for our Sunday newsletter and get your expert content delivered straight to your inbox.
